Brainsway (BWAY) Gross Margin (2018 - 2026)
Brainsway (BWAY) posted quarterly Gross Margin of 75.17% for Q1 2026, up 54.0% year-on-year from 48.81% in Q1 2025, and down 1.66% on a QoQ basis from 76.44% in Q4 2025.
Brainsway (BWAY) Gross Margin (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Gross Margin for 9 consecutive years, with 75.17% the latest figure, recorded in Q1 2026.
- Quarterly Gross Margin rose 54.0% year-over-year to 75.17% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75.51% (up 100.0% YoY) and the FY2025 annual result came in at 75.42%, up 86.0% from the prior year.
- Gross Margin fell to 75.17% in Q1 2026 per BWAY's latest filing, from 76.44% in the prior quarter.
- Over the last five years, Gross Margin for BWAY reached as high as 76.57% in Q1 2022 and fell as low as 71.34% in Q4 2022.
- A 5-year average of 74.39% and a median of 74.64% in 2025 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin slumped 882 bps — and 2023, when it jumped 330 bps.
- Year by year, Gross Margin stood at 71.34% in 2022, then advanced by 5 bps to 74.64% in 2023, then slipped by 0 bps to 74.57% in 2024, then advanced by 3 bps to 76.44% in 2025, then decreased by 2 bps to 75.17% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 75.17%, 76.44%, and 75.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 75.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.17% |
| Dec 31, 2025 | 76.44% |
| Sep 30, 2025 | 75.19% |
| Jun 30, 2025 | 75.20% |
| Mar 31, 2025 | 74.64% |
| Dec 31, 2024 | 74.57% |
| Sep 30, 2024 | 73.52% |
| Jun 30, 2024 | 75.33% |
| Mar 31, 2024 | 74.90% |
| Dec 31, 2023 | 74.64% |
| Sep 30, 2023 | 74.33% |
| Jun 30, 2023 | 73.24% |
| Mar 31, 2023 | 72.95% |
| Dec 31, 2022 | 71.34% |
| Sep 30, 2022 | 74.05% |
| Jun 30, 2022 | 72.62% |
| Mar 31, 2022 | 76.57% |
| Dec 31, 2021 | 77.50% |
| Sep 30, 2021 | 76.06% |
| Jun 30, 2021 | 81.44% |